00919.HK
Modern Healthcare Technology Holdings Limited
HKSE · Consumer Cyclical · Personal Products & Services · HK
HKD 0.08
+4.00%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 899.5M | 442.8M | 453.3M | 454.7M | 406.3M |
| Cost of Revenue | 659.0M | 350.9M | 288.0M | 287.7M | 11.6M |
| Gross Profit | 240.5M | 91.9M | 165.3M | 167.0M | 394.7M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 70.1M | 58.7M | 19.0M | 22.9M | 33.4M |
| General & Admin Expense | 22.0M | — | 16.4M | 18.7M | 30.3M |
| Selling & Marketing Expense | 3.4M | — | 2.6M | 4.2M | 3.1M |
| Other Expenses | 135.6M | — | 144.2M | 148.5M | 8.8M |
| Total Operating Expenses | 205.8M | 58.7M | 163.2M | 171.4M | 395.8M |
| Cost and Expenses | 864.7M | 409.6M | 451.2M | 461.8M | 407.4M |
| Operating Income (EBIT) | 34.8M | 33.2M | 2.1M | 9.5M | (11.9M) |
| Non-Operating | |||||
| Interest Income | 8.3M | 3.5M | 4.8M | 4.1M | 891.0K |
| Interest Expense | 55.7M | 26.4M | 29.3M | 28.6M | 23.4M |
| Net Interest Income | (34.9M) | (23.0M) | (24.5M) | (24.5M) | (22.5M) |
| Other Non-Op Income/Expense | (37.5M) | (32.9M) | (5.1M) | (19.0M) | (6.4M) |
| Non-Operating Income (excl Interest) | (30.3M) | — | 680.0K | (9.6M) | 4.6M |
| EBT (Pre-Tax Income) | (2.7M) | 375.0K | (3.0M) | (9.6M) | (18.3M) |
| Income Tax Expense | 2.6M | 897.0K | 1.7M | (962.0K) | 1.8M |
| Bottom Line | |||||
| Net Income | (6.8M) | (1.8M) | (5.1M) | (9.6M) | (20.6M) |
| Earnings from Cont. Ops | (5.3M) | (522.0K) | (4.8M) | (8.6M) | (20.1M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (6.8M) | (1.8M) | (5.1M) | (9.6M) | (20.6M) |
| Per Share | |||||
| Basic EPS | (HK$0.01) | (HK$0.00) | (HK$0.01) | (HK$0.01) | (HK$0.02) |
| Diluted EPS | (HK$0.01) | (HK$0.00) | (HK$0.01) | (HK$0.01) | (HK$0.02) |
| Revenue Per Share | HK$1.00 | HK$0.49 | HK$0.50 | HK$0.50 | HK$0.45 |
| Shares | |||||
| Basic Shares Outstanding | 902.8M | 904.5M | 904.5M | 904.5M | 904.5M |
| Diluted Shares Outstanding | 902.8M | 904.5M | 904.5M | 904.5M | 904.5M |
| Profitability Metrics | |||||
| EBITDA | 155.2M | 108.2M | 77.1M | 95.7M | 70.7M |
| D&A | 90.1M | 74.9M | 75.7M | 76.6M | 87.2M |
| EBIT | 65.1M | 33.2M | 1.4M | 19.0M | (16.5M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026